<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02751086</url>
  </required_header>
  <id_info>
    <org_study_id>002</org_study_id>
    <nct_id>NCT02751086</nct_id>
  </id_info>
  <brief_title>Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term Outcomes</brief_title>
  <acronym>IMIGASTRICII</acronym>
  <official_title>Prospective, Observational, Multicenter Study on Minimally Invasive Gastrectomy for Gastric Cancer: Robotic, Laparoscopic and Open Surgery Compared on Operative and Follow-up Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Study Group on Minimally Invasive Surgery for Gastric Cancer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>International Study Group on Minimally Invasive Surgery for Gastric Cancer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall purpose is to develop and maintain a multi-institutional database comprising of
      information regarding surgical, clinical and oncological features of patients that will be
      treated for gastric cancer with robotic, laparoscopic or open approaches and subsequent
      follow-up.

      The main objective is to compare the three surgical arms on surgical and clinical outcomes,
      as well as on the oncological follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A review of the scientific literature, which was recently published by the IMIGASTRIC study
      group, aimed to perform a more complete analysis of the current situation regarding
      performing minimally invasive surgery for gastric cancer. Significant limitations were found
      in the analyzed studies, including:

        -  Small samples of patients, mostly low-quality comparative studies

        -  Selection bias in the comparison groups (e.g. stage, extent of lymphadenectomy)

        -  Absence of subgroup analysis in significant research fields

        -  Lack of information on the surgical techniques adopted

      A large prospective multicenter registry could thus be the optimal way to clarify the role of
      minimally invasive surgery for gastric cancer and permit the evaluation of its short and
      long-term effects. A working basis for analyzing outcomes of interest and obtaining
      directions for guidelines and future study developments can also be created. The following
      would be the main advantages of a large prospective multicenter registry:

        -  Achieving a large sample of patients

        -  Collecting multiple variables, allowing for the making of a comprehensive statistical
           report

        -  Standardizing the methodology to be adopted, thus increasing accuracy

        -  Bringing together the experiences of both East and West to discover shared points A
           prospective registry can become a powerful tool that can guide research in this field to
           new developments and pave the way for other investigational opportunities.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients with intraoperative adverse events</measure>
    <time_frame>During surgery</time_frame>
    <description>events other than the normal course of the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean of retrieved lymph nodes</measure>
    <time_frame>Within 30 days after surgery</time_frame>
    <description>Count of retrieved lymph nodes at the histopathological examination of the surgical specimen</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients alive</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>subjects alive at the planned endpoint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients alive</measure>
    <time_frame>2 year after surgery</time_frame>
    <description>subjects alive at the planned endpoint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients alive</measure>
    <time_frame>3 year after surgery</time_frame>
    <description>subjects alive at the planned endpoint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients alive</measure>
    <time_frame>4 year after surgery</time_frame>
    <description>subjects alive at the planned endpoint</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients alive</measure>
    <time_frame>5 year after surgery</time_frame>
    <description>subjects alive at the planned endpoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean post-operative hospital stay</measure>
    <time_frame>from the day after surgery to patient discharge, assessed up to 90 days</time_frame>
    <description>hospital stay of the patients after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications after discharge</measure>
    <time_frame>5 year after surgery</time_frame>
    <description>any surgical related event after patient's discharge</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Robotic Gastrectomy</arm_group_label>
    <description>Patients who will be treated for gastric cancer with the assistance of the robotic surgical system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic Gastrectomy</arm_group_label>
    <description>Patients who will be treated for gastric cancer through laparoscopic devices.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Gastrectomy</arm_group_label>
    <description>Patients who will be treated for gastric cancer with traditional open surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic Gastrectomy</intervention_name>
    <description>Minimally invasive surgical approach, related to the availability of a robotic surgical system (eg Da Vinci surgical system), that allows a surgeon to perform surgery through a console and dedicated devices.</description>
    <arm_group_label>Robotic Gastrectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic Gastrectomy</intervention_name>
    <description>Minimally invasive surgical approach performed through traditional laparoscopy.</description>
    <arm_group_label>Laparoscopic Gastrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with gastric cancer eligible for curative surgery.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically proven gastric cancer

          -  Preoperative staging work-up performed by upper endoscopy and/or endoscopic
             ultrasound, and CT scan and in accordance to international guidelines

          -  Early Gastric Cancer

          -  Advanced Gastric Cancer

          -  Patients treated with curative intent in accordance to international guidelines

        Exclusion Criteria:

          -  Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node
             metastases, Krukenberg tumors, involvement of other organs

          -  Patients with high operative risk as defined by the American Society of
             Anesthesiologists (ASA) score &gt; 4

          -  History of previous abdominal surgery for gastric cancer

          -  Synchronous malignancy in other organs

          -  Palliative surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amilcare Parisi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Mary's Hospital of Terni</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacopo Desiderio, MD</last_name>
    <phone>+393497531121</phone>
    <email>djdesi85@hotmail.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Digestive Surgery, St. Mary's Hospital, University of Perugia</name>
      <address>
        <city>Terni</city>
        <zip>05100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amilcare Parisi</last_name>
      <email>amilcareparisi@virgilio.it</email>
    </contact>
    <contact_backup>
      <last_name>Jacopo Desiderio</last_name>
      <email>djdesi85@hotmail.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.imigastric.com</url>
    <description>Study's website. The study is open to other interested Institutions.</description>
  </link>
  <reference>
    <citation>Parisi A, Nguyen NT, Reim D, Zhang S, Jiang ZW, Brower ST, Azagra JS, Facy O, Alimoglu O, Jackson PG, Tsujimoto H, Kurokawa Y, Zang L, Coburn NG, Yu PW, Zhang B, Qi F, Coratti A, Annecchiarico M, Novotny A, Goergen M, Lequeu JB, Eren T, Leblebici M, Al-Refaie W, Takiguchi S, Ma J, Zhao YL, Liu T, Desiderio J. Current status of minimally invasive surgery for gastric cancer: A literature review to highlight studies limits. Int J Surg. 2015 May;17:34-40. doi: 10.1016/j.ijsu.2015.02.021. Epub 2015 Mar 7. Review.</citation>
    <PMID>25758348</PMID>
  </reference>
  <reference>
    <citation>Parisi A, Desiderio J. Establishing a multi-institutional registry to compare the outcomes of robotic, laparoscopic, and open surgery for gastric cancer. Surgery. 2015 Apr;157(4):830-1. doi: 10.1016/j.surg.2014.12.007. Epub 2015 Jan 26.</citation>
    <PMID>25633739</PMID>
  </reference>
  <reference>
    <citation>Desiderio J, Jiang ZW, Nguyen NT, Zhang S, Reim D, Alimoglu O, Azagra JS, Yu PW, Coburn NG, Qi F, Jackson PG, Zang L, Brower ST, Kurokawa Y, Facy O, Tsujimoto H, Coratti A, Annecchiarico M, Bazzocchi F, Avanzolini A, Gagniere J, Pezet D, Cianchi F, Badii B, Novotny A, Eren T, Leblebici M, Goergen M, Zhang B, Zhao YL, Liu T, Al-Refaie W, Ma J, Takiguchi S, Lequeu JB, Trastulli S, Parisi A. Robotic, laparoscopic and open surgery for gastric cancer compared on surgical, clinical and oncological outcomes: a multi-institutional chart review. A study protocol of the International study group on Minimally Invasive surgery for GASTRIc Cancer-IMIGASTRIC. BMJ Open. 2015 Oct 19;5(10):e008198. doi: 10.1136/bmjopen-2015-008198.</citation>
    <PMID>26482769</PMID>
  </reference>
  <reference>
    <citation>Marano A, Choi YY, Hyung WJ, Kim YM, Kim J, Noh SH. Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer. 2013 Sep;13(3):136-48. doi: 10.5230/jgc.2013.13.3.136. Epub 2013 Sep 30.</citation>
    <PMID>24156033</PMID>
  </reference>
  <reference>
    <citation>Viñuela EF, Gonen M, Brennan MF, Coit DG, Strong VE. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg. 2012 Mar;255(3):446-56. doi: 10.1097/SLA.0b013e31824682f4.</citation>
    <PMID>22330034</PMID>
  </reference>
  <reference>
    <citation>Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4.</citation>
    <PMID>21573742</PMID>
  </reference>
  <reference>
    <citation>Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011 Jun;14(2):101-12. doi: 10.1007/s10120-011-0041-5.</citation>
    <PMID>21573743</PMID>
  </reference>
  <reference>
    <citation>Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.</citation>
    <PMID>19638912</PMID>
  </reference>
  <reference>
    <citation>Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2014 May;40(5):584-91. doi: 10.1016/j.ejso.2013.09.020.</citation>
    <PMID>24685156</PMID>
  </reference>
  <reference>
    <citation>Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010 Dec;17(12):3077-9. doi: 10.1245/s10434-010-1362-z.</citation>
    <PMID>20882416</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2016</study_first_submitted>
  <study_first_submitted_qc>April 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2016</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>International Study Group on Minimally Invasive Surgery for Gastric Cancer</investigator_affiliation>
    <investigator_full_name>Amilcare Parisi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>minimally invasive surgery</keyword>
  <keyword>gastrectomy</keyword>
  <keyword>robotic surgery</keyword>
  <keyword>laparoscopic surgery</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>robot-assisted</keyword>
  <keyword>robotic</keyword>
  <keyword>robotic gastrectomy</keyword>
  <keyword>laparoscopic gastrectomy</keyword>
  <keyword>minimally invasive gastrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol, study information, news</doc_type>
      <doc_url>http://www.imigastric.com</doc_url>
      <doc_comment>The study is open to other interested Institutions.
Correspondance to:
Jacopo Desiderio, MD djdesi85@hotmail.it</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

